iclaprim has been researched along with clarithromycin in 1 studies
| Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) | Studies (clarithromycin) | Trials (clarithromycin) | Recent Studies (post-2010) (clarithromycin) |
|---|---|---|---|---|---|
| 45 | 7 | 16 | 7,149 | 1,606 | 2,504 |
| Protein | Taxonomy | iclaprim (IC50) | clarithromycin (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 5.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3113 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.0903 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karlowsky, JA; Zhanel, GG | 1 |
1 other study(ies) available for iclaprim and clarithromycin
| Article | Year |
|---|---|
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
Topics: Bacteremia; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |